| 1 Number of participants experiencing an attack |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 1.1 Colchicine 0.6 mg orally three times daily (at three months) |
1 |
10 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.21 [0.05, 0.95] |
| 1.2 Colchicine 0.5 mg orally twice daily (at two months) |
1 |
20 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.78 [0.49, 1.23] |
| 1.3 Sensitivity analysis for colchicine 0.5 mg orally twice daily (at two months) ‐ assumed with attack |
1 |
22 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.74 [0.50, 1.08] |
| 1.4 Sensitivity analysis for colchicine 0.5 mg orally twice daily (at two months) ‐ assumed without attack |
1 |
22 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.78 [0.46, 1.32] |
